Market closed
Ginkgo Bioworks/$DNA
Ginkgo Bioworks shares are trading higher after announcing a partnership with Aura Genetics to deploy an advanced automation platform for direct-to-consumer testing.
10 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ginkgo Bioworks
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Ticker
$DNA
Sector
Trading on
NYSE
Industry
Chemicals
Headquarters
Employees
834
Website
Ginkgo Bioworks Metrics
BasicAdvanced
$413M
-
-$10.54
1.24
-
Price and volume
Market cap
$413M
Beta
1.24
52-week high
$45.20
52-week low
$5.00
Average daily volume
1.4M
Financial strength
Current ratio
5.619
Quick ratio
5.445
Long term debt to equity
61.279
Total debt to equity
65.324
Interest coverage (TTM)
-5,092.73%
Management effectiveness
Return on assets (TTM)
-19.67%
Return on equity (TTM)
-60.34%
Valuation
Price to revenue (TTM)
1.737
Price to book
0.58
Price to tangible book (TTM)
0.64
Price to free cash flow (TTM)
-1.032
Growth
Revenue change (TTM)
-9.71%
Earnings per share change (TTM)
-42.62%
3-year revenue growth (CAGR)
-10.23%
3-year earnings per share growth (CAGR)
-42.53%
Ginkgo Bioworks News
AllArticlesVideos
Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways
Business Wire·3 weeks ago
2025 Is Make Or Break For Ginkgo Bioworks
Seeking Alpha·2 months ago
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Ginkgo Bioworks stock?
Ginkgo Bioworks (DNA) has a market cap of $413M as of April 25, 2025.
What is the P/E ratio for Ginkgo Bioworks stock?
The price to earnings (P/E) ratio for Ginkgo Bioworks (DNA) stock is 0 as of April 25, 2025.
Does Ginkgo Bioworks stock pay dividends?
No, Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders as of April 25, 2025.
When is the next Ginkgo Bioworks dividend payment date?
Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Ginkgo Bioworks?
Ginkgo Bioworks (DNA) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.